Sulfuric Acid

Sulfuric Acid

SCHEMBL999149

Fc1cncc2ccccc12.O=S(=O)(O)O

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

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

The experimentally established mechanism targets of Sulfuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRA2A known ✓ P08913 1/20 0.38
ADRA2B known ✓ P18089 1/20 0.38
ADRA2C known ✓ P18825 1/20 0.38
ADRA1A known ✓ P35348 1/20 0.38
ERN1 O75460 3/20 0.43
CYP11B2 P19099 8/20 0.41
CYP11B1 P15538 6/20 0.41
ADORA2A P29274 1/20 0.40
ADORA1 P30542 1/20 0.40
PRKCZ Q05513 1/20 0.39
CYP17A1 P05093 4/20 0.37
KDM4E B2RXH2 2/20 0.37
ALDH1A1 P00352 2/20 0.37
MAPT P10636 1/20 0.37
MAPKAPK2 P49137 1/20 0.35
PARP1 P09874 1/20 0.35
PRKCI P41743 1/20 0.35
PDE4B Q07343 1/20 0.35
HSD17B10 Q99714 1/20 0.35
TDP1 Q9NUW8 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Sulfuric Acid SCHEMBL31560042 1.00 ERN1 (0.43) ERN1CYP11B2CYP11B1ADORA2AADORA1
Sulfuric Acid SCHEMBL31560041 1.00 ERN1 (0.43) ERN1CYP11B2CYP11B1ADORA2AADORA1
SCHEMBL30605416 0.88 CYP11B2 (0.47) ERN1CYP11B2CYP11B1ADORA2AADORA1
SCHEMBL18805059 0.88 CYP11B2 (0.47) ERN1CYP11B2CYP11B1ADORA2AADORA1
SCHEMBL998807 0.88 CYP11B2 (0.47) ERN1CYP11B2CYP11B1ADORA2AADORA1
SCHEMBL28481338 0.83 ALDH1A1 (0.52) ERN1CYP11B2CYP11B1ADORA2AADORA1
SCHEMBL11139164 0.76 ALDH1A1 (0.42) ERN1PRKCZADRA2AADRA2BADRA2C
Hydrochloric Acid SCHEMBL27568567 0.74 CTRB1 (0.42) ERN1PRKCZALDH1A1HSD17B10
Sulfuric Acid SCHEMBL28657307 0.70 ROCK2 (0.45) PRKCZKDM4EPRKCICYP3A4
SCHEMBL998049 0.70 ROCK2 (0.47) PRKCZPRKCICYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-222788965-U 4-Fluoroisoquinoline sulfate impurity removing equipment 大连万福制药有限公司 2025-04-25 CN claimed
CN-112047884-A Synthesis method of 4-fluoroisoquinoline sulfate 沈阳市摩尔医药技术开发有限责任公司 2020-12-08 CN claimed
EP-1852421-B1 PROCESS FOR PRODUCTION OF 4-FLUOROISOQUINOLINE-5-SULFONYL HALIDE OR SALT THEREOF KOWA CO (JP) 2011-05-04 EP claimed
US-7872136-B2 Process for production of 4-fluoroisoquinoline-5-sulfonyl halide or salt thereof KOWA CO., LTD. (JP) 2011-01-18 US claimed
US-20090209765-A1 PROCESS FOR PRODUCTION OF 4-FLUOROISOQUINOLINE-5-SULFONYL HALIDE OR SALT THEREOF KOWA CO., LTD. (JP) 2009-08-20 US claimed
EP-1852421-A1 PROCESS FOR PRODUCTION OF 4-FLUOROISOQUINOLINE-5-SULFONYL HALIDE OR SALT THEREOF Kowa Company, Ltd. (JP) 2007-11-07 EP claimed
CN-222788965-U 4-Fluoroisoquinoline sulfate impurity removing equipment 大连万福制药有限公司 2025-04-25 CN disclosed
CN-222788965-U 4-Fluoroisoquinoline sulfate impurity removing equipment 大连万福制药有限公司 2025-04-25 CN disclosed
CN-112047884-A Synthesis method of 4-fluoroisoquinoline sulfate 沈阳市摩尔医药技术开发有限责任公司 2020-12-08 CN disclosed
CN-112047884-A Synthesis method of 4-fluoroisoquinoline sulfate 沈阳市摩尔医药技术开发有限责任公司 2020-12-08 CN disclosed
CN-112047884-A Synthesis method of 4-fluoroisoquinoline sulfate 沈阳市摩尔医药技术开发有限责任公司 2020-12-08 CN disclosed
EP-1852421-B1 PROCESS FOR PRODUCTION OF 4-FLUOROISOQUINOLINE-5-SULFONYL HALIDE OR SALT THEREOF KOWA CO (JP) 2011-05-04 EP disclosed
US-7872136-B2 Process for production of 4-fluoroisoquinoline-5-sulfonyl halide or salt thereof KOWA CO., LTD. (JP) 2011-01-18 US disclosed
US-20090209765-A1 PROCESS FOR PRODUCTION OF 4-FLUOROISOQUINOLINE-5-SULFONYL HALIDE OR SALT THEREOF KOWA CO., LTD. (JP) 2009-08-20 US disclosed
EP-1852421-A1 PROCESS FOR PRODUCTION OF 4-FLUOROISOQUINOLINE-5-SULFONYL HALIDE OR SALT THEREOF Kowa Company, Ltd. (JP) 2007-11-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090209765-A1 PROCESS FOR PRODUCTION OF 4-FLUOROISOQUINOLINE-5-SULFONYL HALIDE OR SALT THEREOF SALL4, STS, SFPQ ADRA2A 3883/4885ADRA2B 3879/4885ADRA2C 3161/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.